Invivoscribe
Invivoscribe is a biotechnology company specializing in precision diagnostic products and services for leukemias and lymphomas, offering a range of internationally standardized tests and Next-Generation Sequencing (NGS) products.
Services
Invivoscribe offers precision diagnostic products and services focused on leukemias and lymphomas. They provide internationally standardized testing of novel and proprietary biomarkers. They also operate clinical lab services through LabPMM, with locations in the USA, Germany, and Japan. Moreover, Invivoscribe participates in global regulatory expertise and partnerships aimed at accelerating drug approvals.
Products
Invivoscribe's product portfolio includes Next-Generation Sequencing (NGS) products such as CE-IVD and RUO assays for Illumina and Thermo Fisher platforms. They offer Companion Diagnostics (CDx) tests, including the LeukoStrat CDx FLT3 Mutation Assay. Additionally, the company provides ABI Fluorescence Detection and Gel Detection products for clonality and FLT3 analysis, a range of controls including Master Mix, DNA, RNA, and MRD controls, as well as various reagents like ASRs, enzymes, and Hi-Di Formamide.
Software Solutions
Invivoscribe offers several software solutions designed to enhance diagnostic accuracy and efficiency. These include Dockerized FLT3 ITD MRD software and LymphoTrack Enterprise Software, which are essential for detailed analysis and data interpretation in clinical settings.
Clinical Lab Services
The company operates clinical lab services under the name LabPMM, with laboratories located in the USA, Germany, and Japan. These labs provide a wide range of diagnostic testing and analytical services, ensuring international standards and high-quality results.